El caso de Singulair, un medicamento para el asma que provocó angustianews2024-01-17T13:18:21+00:00January 17th, 2024|The New York Times|
F.D.A. Warned of Mental Side Effects from Asthma Drug, Singulair. Few Were Told.news2024-01-09T10:03:02+00:00January 9th, 2024|The New York Times|
F.D.A. to Issue First Approval for Mass Drug Imports to States from Canadanews2024-01-05T18:06:59+00:00January 5th, 2024|The New York Times|
Sidney M. Wolfe, Scourge of the Pharmaceutical Industry, Dies at 86news2024-01-03T20:08:54+00:00January 3rd, 2024|The New York Times|
A Rejected A.L.S. Drug Made Me Rethink the Role of Hope in Medicinenews2023-12-25T14:00:10+00:00December 25th, 2023|The New York Times|
We Need to Rethink Our Treatment of Painnews2023-12-24T14:00:21+00:00December 24th, 2023|The New York Times|
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billionnews2023-12-22T17:55:31+00:00December 22nd, 2023|The New York Times|
Fake Ozempic Found in U.S., F.D.A. Warnsnews2023-12-22T16:06:00+00:00December 22nd, 2023|The New York Times|
Possible Ways to Ease Drug Shortagesnews2023-12-19T16:05:37+00:00December 19th, 2023|The New York Times|
Behind the Shortage Keeping Cancer Patients From Chemonews2023-12-19T08:01:01+00:00December 19th, 2023|The New York Times|